{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:49:59Z","timestamp":1787165399355,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-02551-x","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T08:06:48Z","timestamp":1748419608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular genetic analysis of pulmonary benign metastasizing leiomyoma and intravenous leiomyomatosis: a comparative study using whole exome sequencing"],"prefix":"10.1007","volume":"16","author":[{"given":"Jin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"issue":"Suppl 5","key":"2551_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1289\/ehp.00108s5779","volume":"108","author":"SJ Robboy","year":"2000","unstructured":"Robboy SJ, Bentley RC, Butnor K, et al. Pathology and pathophysiology of uterine smooth-muscle tumors. Environ Health Perspect. 2000;108(Suppl 5):779\u201384.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"2551_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12905-023-02237-y","volume":"23","author":"T Tong","year":"2023","unstructured":"Tong T, Fan Q, Wang Y, et al. Benign metastasizing uterine leiomyoma with lymphatic and pulmonary metastases: a case report and literature review. BMC women\u2019s health. 2023;23(1):154.","journal-title":"BMC women\u2019s health"},{"issue":"1","key":"2551_CR3","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1093\/oncolo\/oyab019","volume":"27","author":"J Boavida Ferreira","year":"2022","unstructured":"Boavida Ferreira J, Cabrera R, Santos F, et al. Benign metastasizing leiomyomatosis to the skin and lungs, intravenous leiomyomatosis, and leiomyomatosis peritonealis disseminata: a series of five cases. Oncologist. 2022;27(1):e89\u201398.","journal-title":"Oncologist"},{"issue":"4","key":"2551_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175875","volume":"12","author":"E Barna\u015b","year":"2017","unstructured":"Barna\u015b E, Ksi\u0105\u017cek M, Ra\u015b R, et al. Benign metastasizing leiomyoma: a review of current literature in respect to the time and type of previous gynecological surgery. PLoS ONE. 2017;12(4): e0175875.","journal-title":"PLoS ONE"},{"issue":"1","key":"2551_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12890-020-01330-4","volume":"20","author":"R Fan","year":"2020","unstructured":"Fan R, Feng F, Yang H, et al. Pulmonary benign metastasizing leiomyomas: a case series of 23 patients at a single facility. BMC Pulm Med. 2020;20(1):292.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"2551_CR6","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.athoracsur.2015.05.107","volume":"101","author":"J Miller","year":"2016","unstructured":"Miller J, Shoni M, Siegert C, et al. Benign metastasizing leiomyomas to the lungs: an institutional case series and a review of the recent literature. Ann Thorac Surg. 2016;101(1):253\u20138.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"2551_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jvs.2003.08.012","volume":"39","author":"PM Lam","year":"2004","unstructured":"Lam PM, Lo KWK, Yu MY, et al. Intravenous leiomyomatosis: two cases with different routes of tumor extension. J Vasc Surg. 2004;39(2):465\u20139.","journal-title":"J Vasc Surg"},{"issue":"2","key":"2551_CR8","first-page":"140","volume":"33","author":"J Lin","year":"2014","unstructured":"Lin J, Song X, Liu C. Pelvic intravascular leiomyomatosis associated with benign pulmonary metastasizing leiomyoma: Clinicopathologic, clonality, and copy number variance analysis. IJGP. 2014;33(2):140\u20135.","journal-title":"IJGP"},{"key":"2551_CR9","unstructured":"Hu S S, Wang L L, Zhao H, et al. [Clinicopathological features and gene phenotypes of benign metastasizing leiomyoma]. Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology, 2020, 49(7): 704\u2013709."},{"key":"2551_CR10","unstructured":"Gynecologic Oncology Subgroup, Chinese Obstetricians and Gynecologists Association. [Chinese expert consensus on clinical diagnosis and treatment of pelvic venous leiomyomatosis]. Zhonghua Fu Chan Ke Za Zhi, 2023, 58(4): 252\u2013258."},{"issue":"10","key":"2551_CR11","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/modpathol.2016.107","volume":"29","author":"B Liegl-Atzwanger","year":"2016","unstructured":"Liegl-Atzwanger B, Heitzer E, Flicker K, et al. Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors. Modern Pathol. 2016;29(10):1262\u201377.","journal-title":"Modern Pathol"},{"issue":"8","key":"2551_CR12","first-page":"FSO14","volume":"8","author":"MA AlQudah","year":"2022","unstructured":"AlQudah MA, Hamouri S, Haddad HK, et al. Pulmonary benign metastasizing leiomyoma: A report of two cases. Fut Sci OA. 2022;8(8):FSO14.","journal-title":"Fut Sci OA"},{"issue":"6","key":"2551_CR13","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.prp.2018.04.011","volume":"214","author":"L Tang","year":"2018","unstructured":"Tang L, Lu B. Intravenous leiomyomatosis of the uterus: a clinicopathologic analysis of 13 cases with an emphasis on histogenesis. Pathol Res Pract. 2018;214(6):871\u20135.","journal-title":"Pathol Res Pract"},{"key":"2551_CR14","volume":"27","author":"K Ofori","year":"2019","unstructured":"Ofori K, Fernandes H, Cummings M, et al. Benign metastasizing leiomyoma presenting with miliary pattern and fatal outcome: case report with molecular analysis & review of the literature. Respir Med Case Rep. 2019;27: 100831.","journal-title":"Respir Med Case Rep"},{"issue":"2","key":"2551_CR15","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4143\/crt.2011.43.2.131","volume":"43","author":"G Yoon","year":"2011","unstructured":"Yoon G, Kim TJ, Sung CO, et al. Benign metastasizing leiomyoma with multiple lymph node metastasis: a case report. Cancer Res Treat. 2011;43(2):131\u20133.","journal-title":"Cancer Res Treat"},{"issue":"7","key":"2551_CR16","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1016\/j.fertnstert.2013.01.147","volume":"99","author":"EI Lewis","year":"2013","unstructured":"Lewis EI, Chason RJ, DeCherney AH, et al. Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review. Fertil Steril. 2013;99(7):2017\u201324.","journal-title":"Fertil Steril"},{"issue":"1","key":"2551_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13023-020-01394-9","volume":"15","author":"H Li","year":"2020","unstructured":"Li H, Xu J, Lin Q, et al. Surgical treatment strategies for extra-pelvic intravenous leiomyomatosis. Orphanet J Rare Dis. 2020;15(1):153.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2551_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/OGX.0b013e3181d60f93","volume":"65","author":"AO Awonuga","year":"2010","unstructured":"Awonuga AO, Shavell VI, Imudia AN, et al. Pathogenesis of benign metastasizing leiomyoma: a review. Obstet Gynecol Surv. 2010;65(3):189\u201395.","journal-title":"Obstet Gynecol Surv"},{"issue":"5","key":"2551_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00404-006-0165-8","volume":"274","author":"JH Egberts","year":"2006","unstructured":"Egberts JH, Schafmayer C, Bauerschlag DO, et al. Benign abdominal and pulmonary metastasizing leiomyoma of the uterus. Arch Gynecol Obstet. 2006;274(5):319\u201322.","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"2551_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/01.pas.0000213414.15633.4e","volume":"31","author":"MR Nucci","year":"2007","unstructured":"Nucci MR, Drapkin R, Dal Cin P, et al. Distinctive cytogenetic profile in benign metastasizing leiomyoma: Pathogenetic implications. Am J Surg Pathol. 2007;31(5):737\u201343.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2551_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12881-018-0537-5","volume":"19","author":"D S\u00f5ritsa","year":"2018","unstructured":"S\u00f5ritsa D, Teder H, Roosipuu R, et al. Whole exome sequencing of benign pulmonary metastasizing leiomyoma reveals mutation in the BMP8B gene. BMC Med Genet. 2018;19(1):20.","journal-title":"BMC Med Genet"},{"issue":"8","key":"2551_CR22","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s12094-018-1847-y","volume":"20","author":"J Jiang","year":"2018","unstructured":"Jiang J, He M, Hu X, et al. Deep sequencing reveals the molecular pathology characteristics between primary uterine leiomyoma and pulmonary benign metastasizing leiomyoma. Clin Transl Oncol. 2018;20(8):1080\u20136.","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"2551_CR23","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1002\/cncr.2820360638","volume":"36","author":"MR Abell","year":"1975","unstructured":"Abell MR, Littler ER. Benign metastasizing uterine leiomyoma. Multiple lymph nodal metastases. Cancer. 1975;36(6):2206\u201313.","journal-title":"Cancer"},{"issue":"5","key":"2551_CR24","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10147-010-0156-4","volume":"16","author":"M Mizuno","year":"2011","unstructured":"Mizuno M, Nawa A, Nakanishi T, et al. Clinical benefit of endocrine therapy for benign metastasizing leiomyoma. Int J Clin Oncol. 2011;16(5):587\u201391.","journal-title":"Int J Clin Oncol"},{"issue":"9","key":"2551_CR25","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.humpath.2014.05.010","volume":"45","author":"N Buza","year":"2014","unstructured":"Buza N, Xu F, Wu W, et al. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: High-resolution array comparative genomic hybridization study. Hum Pathol. 2014;45(9):1885\u201392.","journal-title":"Hum Pathol"},{"issue":"5","key":"2551_CR26","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/modpathol.2016.36","volume":"29","author":"Z Ordulu","year":"2016","unstructured":"Ordulu Z, Nucci MR, Dal Cin P, et al. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol. 2016;29(5):500\u201310.","journal-title":"Mod Pathol"},{"issue":"13","key":"2551_CR27","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1002\/cam4.3098","volume":"9","author":"W Wang","year":"2020","unstructured":"Wang W, Wang Y, Chen F, et al. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation. Cancer Med. 2020;9(13):4581\u201392.","journal-title":"Cancer Med"},{"issue":"2","key":"2551_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/emmm.201303373","volume":"6","author":"M Romagnoli","year":"2014","unstructured":"Romagnoli M, Mineva ND, Polmear M, et al. ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis. EMBO Mol Med. 2014;6(2):278\u201394.","journal-title":"EMBO Mol Med"},{"issue":"7","key":"2551_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1158\/1541-7786.MCR-10-0449","volume":"9","author":"T Nishisho","year":"2011","unstructured":"Nishisho T, Hata K, Nakanishi M, et al. The a3 isoform vacuolar type H+-ATPase promotes distant metastasis in the mouse B16 melanoma cells. MCR. 2011;9(7):845\u201355.","journal-title":"MCR"},{"issue":"29","key":"2551_CR30","doi-asserted-by":"publisher","first-page":"11248","DOI":"10.1074\/jbc.RA119.007713","volume":"294","author":"CM McGuire","year":"2019","unstructured":"McGuire CM, Collins MP, Sun-Wada G, et al. Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells. J Biol Chem. 2019;294(29):11248\u201358.","journal-title":"J Biol Chem"},{"issue":"1","key":"2551_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.166","volume":"50","author":"HD Yang","year":"2018","unstructured":"Yang HD, Eun JW, Lee KB, et al. T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma. Exp Mol Med. 2018;50(1): e420.","journal-title":"Exp Mol Med"},{"issue":"4","key":"2551_CR32","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3892\/ol.2021.12514","volume":"21","author":"C Qi","year":"2021","unstructured":"Qi C, Lei L, Hu J, et al. T cell immune regulator 1 is a prognostic marker associated with immune infiltration in glioblastoma multiforme. Oncol Lett. 2021;21(4):252.","journal-title":"Oncol Lett"},{"issue":"19","key":"2551_CR33","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.3390\/cancers14194583","volume":"14","author":"C Xu","year":"2022","unstructured":"Xu C, Jia B, Yang Z, et al. Integrative analysis identifies TCIRG1 as a potential prognostic and immunotherapy-relevant biomarker associated with malignant cell migration in clear cell renal cell carcinoma. Cancers. 2022;14(19):4583.","journal-title":"Cancers"},{"issue":"1","key":"2551_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12935-023-03019-0","volume":"23","author":"S Di","year":"2023","unstructured":"Di S, Gong M, Lv J, et al. Glycolysis-related biomarker TCIRG1 participates in regulation of renal cell carcinoma progression and tumor immune microenvironment by affecting aerobic glycolysis and AKT\/mTOR signaling pathway. Cancer Cell Int. 2023;23(1):186.","journal-title":"Cancer Cell Int"},{"issue":"11","key":"2551_CR35","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1158\/1535-7163.MCT-10-0511","volume":"9","author":"I Lee","year":"2010","unstructured":"Lee I, Park C, Kang WK. Knockdown of inwardly rectifying potassium channel Kir2.2 suppresses tumorigenesis by inducing reactive oxygen species-mediated cellular senescence. Mole Cancer Ther. 2010;9(11):2951\u20139.","journal-title":"Mole Cancer Ther"},{"issue":"3","key":"2551_CR36","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1158\/0008-5472.CAN-12-2498","volume":"73","author":"I Lee","year":"2013","unstructured":"Lee I, Lee SJ, Kang TM, et al. Unconventional role of the inwardly rectifying potassium channel Kir2.2 as a constitutive activator of RelA in cancer. Cancer Res. 2013;73(3):1056\u201362.","journal-title":"Cancer Res"},{"key":"2551_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cancergen.2017.11.011","volume":"221","author":"N Khalilipour","year":"2018","unstructured":"Khalilipour N, Baranova A, Jebelli A, et al. Familial esophageal squamous cell carcinoma with damaging rare\/germline mutations in KCNJ12\/KCNJ18 and GPRIN2 genes. Cancer Genet. 2018;221:46\u201352.","journal-title":"Cancer Genet"},{"issue":"6","key":"2551_CR38","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s10565-021-09668-z","volume":"38","author":"G Li","year":"2022","unstructured":"Li G, Guo BY, Wang HD, et al. CircRNA hsa_circ_0014130 function as a miR-132-3p sponge for playing oncogenic roles in bladder cancer via upregulating KCNJ12 expression. Cell Biol Toxicol. 2022;38(6):1079\u201396.","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"2551_CR39","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/modpathol.3800504","volume":"19","author":"KT Patton","year":"2006","unstructured":"Patton KT, Cheng L, Papavero V, et al. Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis. Mod Pathol. 2006;19(1):130\u201340.","journal-title":"Mod Pathol"},{"issue":"3","key":"2551_CR40","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/PDM.0b013e31815aca19","volume":"17","author":"GJ Nuovo","year":"2008","unstructured":"Nuovo GJ, Schmittgen TD. Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses. Diagnostic Mol Pathol. 2008;17(3):145\u201350.","journal-title":"Diagnostic Mol Pathol"},{"issue":"6","key":"2551_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/PAP.0000000000000446","volume":"31","author":"A Pinto","year":"2024","unstructured":"Pinto A. Uterine smooth muscle tumors: an overview. Adv Anat Pathol. 2024;31(6):397\u2013410.","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"2551_CR42","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","volume":"18","author":"SW Bell","year":"1994","unstructured":"Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994;18(6):535\u201358.","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2551_CR43","first-page":"209","volume":"2","author":"AA Gal","year":"1989","unstructured":"Gal AA, Brooks JS, Pietra GG. Leiomyomatous neoplasms of the lung: a clinical, histologic, and immunohistochemical study. Mod Pathol. 1989;2(3):209\u201316.","journal-title":"Mod Pathol"},{"issue":"12","key":"2551_CR44","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.5858\/2009-0576-RS.1","volume":"134","author":"X Zhang","year":"2010","unstructured":"Zhang X, Travis WD. Pulmonary lymphangioleiomyomatosis. Arch Pathol Lab Med. 2010;134(12):1823\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"2551_CR45","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13000-014-0224-6","volume":"9","author":"RJC Vogels","year":"2014","unstructured":"Vogels RJC, Vlenterie M, Versleijen-Jonkers YMH, et al. Solitary fibrous tumor\u2014clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9:224.","journal-title":"Diagn Pathol"},{"issue":"4","key":"2551_CR46","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0022-5223(19)40191-8","volume":"71","author":"RM Becker","year":"1976","unstructured":"Becker RM, Viloria J, Chiu C. Multiple pulmonary leiomyomatous hamartomas in women. J Thorac Cardiovasc Surg. 1976;71(4):631\u20132.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"12","key":"2551_CR47","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/pin.12222","volume":"64","author":"K Okudela","year":"2014","unstructured":"Okudela K, Umeda S, Otara M, et al. A case of pulmonary hamartoma with distinctive histopathological features: A discussion of its differential diagnosis and histogenesis. Pathol Int. 2014;64(12):618\u201323.","journal-title":"Pathol Int"},{"issue":"9","key":"2551_CR48","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/s41379-020-0546-8","volume":"33","author":"Z Ordulu","year":"2020","unstructured":"Ordulu Z, Chai H, Peng G, et al. Molecular and clinicopathologic characterization of intravenous leiomyomatosis. Mod Pathol. 2020;33(9):1844\u201360.","journal-title":"Mod Pathol"},{"issue":"2","key":"2551_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pathol.2019.10.009","volume":"52","author":"B Lu","year":"2020","unstructured":"Lu B, Liu Q, Tang L, et al. Intravenous leiomyomatosis: molecular analysis of 17 cases. Pathology. 2020;52(2):213\u20137.","journal-title":"Pathology"},{"key":"2551_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ygyno.2023.02.009","volume":"171","author":"A Gadducci","year":"2023","unstructured":"Gadducci A, Multinu F, De Vitis LA, et al. Endometrial stromal tumors of the uterus: epidemiology, pathological and biological features, treatment options and clinical outcomes. Gynecol Oncol. 2023;171:95\u2013105.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"2551_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cancergen.2012.04.005","volume":"205","author":"JM Bowen","year":"2012","unstructured":"Bowen JM, Cates JM, Kash S, et al. Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet. 2012;205(5):249\u201354.","journal-title":"Cancer Genet"},{"issue":"2","key":"2551_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/gcc.10159","volume":"36","author":"P Dal Cin","year":"2003","unstructured":"Dal Cin P, Quade BJ, Neskey DM, et al. Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24). Genes Chromosom Cancer. 2003;36(2):205\u20136.","journal-title":"Genes Chromosom Cancer"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-02551-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-02551-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T09:03:35Z","timestamp":1748423015000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-02551-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2551"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-02551-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the Ethics Committee of the Affiliated Hospital of Zunyi Medical University. Written informed consent was obtained from the patient and the patient's family for publication of this clinical case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient and the patient's family for publication of this case report and any accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"939"}}